Showing results (91-100 of 116) with videos related to
Sort By:
Pageof 12
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|March 12, 2014
Analysis of lymphatic and blood vessel invasion biomarkers in T1 esophagogastric adenocarcinomas for improved patient prognosticationC Perry, I Soomro, P Kaye, et al.Clinical Nutrition (Edinburgh, Scotland)|October 16, 2012
Guidelines for perioperative care in elective rectal/pelvic surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendationsJ Nygren, J Thacker, F Carli, et al.Clinical Endocrinology|December 1, 1995
Cardiovascular and metabolic responses to adrenaline infusion in patients with short-term hypothyroidismA B Johnson, J Webber, P Mansell, et al.British Journal of Cancer|May 13, 2010
Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapyK R Fareed, A Al-Attar, I N Soomro, et al.World Journal of Surgery|March 5, 2016
Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society RecommendationsA Thorell, A D MacCormick, S Awad, et al.British Journal of Anaesthesia|October 19, 2014
Choice of fluid in acute illness: what should be given? An international consensusK Raghunathan, P T Murray, W S Beattie, et al.Anaesthesia|July 7, 2023
Risks and benefits of oral modified-release compared with oral immediate-release opioid use after surgery: a systematic review and meta-analysisS Liu, A Athar, D Quach, et al.Clinical Nutrition (Edinburgh, Scotland)|August 1, 1990
Low anthropometric indices in elderly females with fractured neck of femurP I Mansell, J Rawlings, S P Allison, et al.Diabetic Medicine : a Journal of the British Diabetic Association|September 1, 1988
Group education for obese patients with type 2 diabetes: greater success at less costS R Heller, P Clarke, H Daly, et al.British Journal of Cancer|January 21, 2010
Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancersA Al-Attar, L Gossage, K R Fareed, et al.Pageof 12